SAMLYN CAPITAL, LLC - Significant Ownership

Signature - Title
Robert Pohly - Manager
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by SAMLYN CAPITAL, LLC.

Significant Ownership of SAMLYN CAPITAL, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CRVS Corvus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 9.8% $30.9M 6.67M Samlyn Capital, LLC Dec 31, 2024
PCT PureCycle Technologies, Inc. Common Stock, par value $0.001 per share 6.5% $84.4M 11.7M Samlyn Capital, LLC Dec 31, 2024
VINP Vinci Partners Investments Ltd. Class A Common Shares, par value US$0.00005 per share 6.2% $22.6M 2.36M Samlyn Capital, LLC Dec 31, 2024
NKTR NEKTAR THERAPEUTICS Common Stock, $0.0001 par value 5.2% $7.93M 9.67M Samlyn Capital, LLC Dec 31, 2024
INZY Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share 0% $0 0 Samlyn Capital, LLC Dec 31, 2024

Schedules 13D/G Reported by SAMLYN CAPITAL, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.